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Introduction
            Fetal tachycardia, first recognized in 1930 by Hyman et al1, is a condition occurring in
approximately 0.4-0.6% of all pregnancies2. A subset of these cases with more sustained periods
of tachycardia is clinically relevant. The necessity of therapeutic intervention in this condition is
still a matter of discussion focused on the natural history of the disease. The spectrum of
opinions varies from non-intervention3,4,5 based on a number of cases in which the tachycardia
subsided spontaneously6, to aggressive pharmacotherapeutic intervention7,8   based on reports of
deterioration of the fetal condition ultimately ending in significant neurological morbidity9,10,11,
or fetal demise12,13,14. Prenatal treatment through indirect, maternally administered drug therapy
seems to be the preference of most centers15,16,17,18,19,20,21. This matter will be discussed further
in Fetal Tachyarrhythmia, Part II, Treatment.
            The choice of the specific pharmacotherapeutic agents and the chances on success of
therapy depend largely on the type of tachycardia. The determination of the type of tachycardia is
therefore of the utmost importance20,22, however the available diagnostic armamentarium is
limited.   The   most   widely   used   method   of   diagnosis   of   fetal   tachycardia,   M-mode
echocardiography, provides a time related documentation of function of the various cardiac
structures. The current subdivision into supraventricular tachycardia (SVT), atrial flutter (AF)
and ventricular tachycardia (VT) derived from M-mode echocardiography is not sufficient
enough for differentiation according to the electrophysiologic mechanism. Several attempts have
been made in the last years to increase the accuracy and reliability of M-mode echocardiography
by measurement of atrioventricular (AV) and ventriculoatrial (VA) intervals23,24,    and the
addition   of   Doppler   echocardiography25,26.   New   methods   registering   the   actual
electrophysiologic   events   are   in   development   including   noninvasive   techniques   such   as
magnetocardiography(MCG)27. Characteristics of the most common types of fetal tachycardia
are described and examples of M-mode echocardiography and FMCG are presented.
Definitions of tachycardia
            The normal fetal heart rate ranges are approximately 120-160 bpm at 30 weeks and 110-
150 bpm at term28,29. Frequencies up to 170 bpm are considered mildly abnormal, whereas overt
tachycardia is usually defined as a heart rate exceeding 170 bpm 28 or 180 bpm22. These rhythm
abnormalities of the fetus are usually noticed at routine prenatal visits. Fetal echocardiography is
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used to exclude structural cardiac defects and used to position the M-mode sampling line to
intercept both the atrial and ventricular walls. The relationship between peak atrial and
ventricular systolic excursions currently provides a division into SVT, AF and VT.
            Fetal magnetocardiography, a technique recording the magnetic field generated by the
electrical   activity  of   the   fetal   heart27,30,   offers   a   more   precise   delineation   of   the   fetal
electrophysiology.   Detection   occurs   non-invasively   by   sensors   cooled   by   liquid   helium
positioned several centimeters above the maternal abdomen in a magnetically shielded room. As
the   maternal   heart   generates   magnetic   activity   as   well,   a   maternal   ECG   is   recorded
simultaneously and substracted from the fetal MCG. This way, an averaged one lead fetal MCG
is obtained and allows for a more detailed differentiation of the type of tachycardia.
Premature Atrial Contractions
            Premature atrial contractions (PAC’s) do not qualify as a form of fetal tachycardia, and
are associated with good outcome. However, in approximately 0.4 % of cases, it may progress to
runs of tachycardia and even become persistent. It is therefore recommended that these patients
are monitored weekly by doptone to exclude the presence of runs of tachycardia12,16. M-mode
echocardiography  will   show  premature  atrial   contractions   not  followed   by  a  ventricular
contraction and a subsequent ‘drop’ in heart rate (Figure 1).
 
    
Figure 1: M-mode echocardiography of a premature atrial contraction (PAC).
The FMCG will show a premature P-wave not followed by a QRS complex (Figure 2). 
 
  
 
Figure 2: FMCG of a PAC (black arrow).
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Atrial Flutter 
            AF is a condition that accounts for approximately 21 – 50 % of fetal tachycardia and may
be associated with structural abnormalities14, 21,31. It is defined as an atrial rate ranging from 250
up to 500 bpm with a fixed or variable AV block, as the AV-node is not able to conduct every
contraction of the atrium which results in a 2:1 or 3:1 conduction to the ventricles. Rarely in
some cases paroxysmal 1:1 conduction is seen. It may be either paroxysmal or incessant in
nature and is reported to be associated with fetal hydrops in 7 – 43 % of cases14,18,31,32. The most
common electrophysiologic mechanism in AF is a re-entry circuit confined to the atrium. M-
mode echocardiography will show typical atrial contractions that are followed by ventricular
contractions every 2 or 3 atrial contractions (Figure 3).
 
 
Figure 3: M-mode echocardiography of AF. Flutter contractions of the atrium are indicated by
the small arrows; atrioventricular conduction is 2:1 and ventricular contractions are indicated by
the large arrows.
FMCG will show typical flutter waves (P-waves) followed by QRS complexes every 2-3 P-
waves (Figure 4.1).
 
 
Figure 4.1: Raw FMCG trace of atrial flutter with 2:1 conduction.
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Figure 4.2: Averaged FMCG trace of atrial flutter with 2:1 conduction.
Supraventricular tachycardia
            SVT is reported to account for 47 – 68 % of cases of fetal tachycardia14,18,21 and is
associated with a low percentage of structural abnormalities in 2 % of cases. It is defined by a
1:1   atrioventricular   conduction   in   which   the   atrial   contraction   precedes   the   ventricular
contraction. Heart rates in SVT most commonly range from 200-300 bpm, is either paroxysmal
or incessant in nature and associated with fetal hydrops in 36 - 64 %14,33. The condition has
several different underlying electrophysiologic mechanisms, such as re-entry using an accessory
atrioventricular  connection   (AVRT),   which   may  be  either  apparent   or   concealed.  Other
possibilities include primary atrial tachycardias and re-entry within the AV node34. 
            The diagnosis of these specific types of fetal tachycardia is difficult, if not impossible,
with the most widely used current technology, M-mode echocardiography. As mentioned in the
introduction, several studies have been conducted to allow for a more specified diagnosis using
Doppler and M-mode echocardiography. These techniques are based on the relationship in time
between atrial and ventricular wall excursions on M-mode, and flow patterns over the AV and
semilunar valve orifices. In most re-entrant tachycardias, conduction through the accessory
connection is fast, as in the Wolff-Parkinson-White syndrome (WPW). This results in a short RP
interval on the postnatal ECG, comparable to a short VA interval on M-mode (Figure 5.1). In
several patients, slow conduction is observed in the accessory pathway, as in Persistent
Junctional Reciprocating Tachycardia (PJRT) and Atrial Ectopic Tachycardia (AET)26, resulting
in   a   long   RP   interval   on   the   ECG,   comparable   to   a   long   VA   interval   on   M-mode
echocardiography (Figure 5.2). In the literature there has been one case diagnosed as Junctional
Ectopic Tachycardia (JET) by Doppler echocardiography35. It is extremely rare and we have not
encountered JET in the prenatal situation at our center.
               The  detailed  electrophysiological  events   however,   are  irretrievable  by  M-mode
echocardiography. Specific types of fetal tachycardia have been detected and published using
FMCG36,37. A more detailed configuration, comparable to the postnatal ECG is obtained. An
example of this category of fetal SVT’s is shown in Figure 6.
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Figure 5.1: M-mode echocardiography of a SVT with a short VA interval. First white line
placed on the peak excursion of the left atrium wall, second line placed on the peak excursion of
the right ventricle wall, third line on the consecutive peak atrial wall excursion. The AV interval
is markedly longer than the VA interval.
 Figure 5.2: M-mode echocardiography of a SVT with a long VA interval.
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Figure 6: FMCG of a fetal SVT
            The electrophysiologic events are clearly defined in this situation, however, a precise
diagnosis is still debatable. The SVT shown in Figure 6 for instance, may be AVRT using a
concealed accessory pathway, but could also be attributed to represent a PJRT.   
Ventricular Tachycardia
              VT in the prenatal situation is rare and has only been reported occasionally in the
international literature5,16. It is usually paroxysmal in nature and outcome depends on the
electrophysiologic mechanism. Of the utmost importance is the diagnosis of the congenital Long
QT syndrome (LQTS). The origin of this arrhythmia lies in malfunctioning myocardial ion
channels as a result of mutations in genes encoding these ion channels. It is characterised by
prolongation of the QT interval and the occurrence of polymorphic ventricular arrhythmia (such
as Torsade de Pointes). Patients with the LQTS are predisposed to ventricular fibrillation and
sudden death38,39. The prenatal diagnosis is focused on fetuses of mothers with prolonged QT
syndrome to document the possible presence of this syndrome in the fetus. In addition, fetuses
presenting with (baseline) bradycardia or intermittent ventricular tachycardia of the torsade de
pointe type, the diagnosis of LQTS must be considered as well, as spontaneous mutations have
been reported. The suspicion of fetal LQTS may be raised in case M-mode echocardiography
shows (baseline) bradycardia varying from 60-110 bpm and intermittent ventricular tachycardia
in which there is atrioventricular dissociation. FMCG shows a prolonged QT interval (Figure 7),
and the possible presence of intermittent VT40,41.
 
Conclusions
            Fetal tachycardia is a rare disorder, in which difficulties are encountered in the diagnosis
of the exact underlying electrophysiological mechanism and is therefore probably underreported.
The spectrum of pathologic symptomatology varies from an infrequent paroxysmal tachycardia
to a persistent form, which may deteriorate in fetal hydrops, neurological morbidity and even
fetal demise. The presence of fetal tachycardia therefore deserves more attention and requires a
specialized evaluation to define its electrophysiologic diagnosis.
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Figure 7: The QT interval is 319 ms, RR interval is 430 ms, QTc interval is 486 ms. 
            Fetal atrial flutter is a frequently encountered form of fetal tachycardia and can be well
diagnosed by either M-mode echocardiography or FMCG. Fetal SVT remains the most
complicated form of fetal tachycardia, both in diagnosis as in treatment. The difficulty in
delineating an accurate diagnosis of the specific form and the relative therapy resistance of the
various subtypes of this tachycardia, for instance PJRT, makes the development of an optimal
treatment protocol complicated.
            The most infrequent encountered form of tachycardia is fetal VT, however, if present, it
has very serious implications for the fetus. In utero management is complicated and yields a
limited success but it is also predictive for an uncertain future after birth. Improved prenatal
diagnostic techniques may support a better understanding of the pathophysiology, but does not
necessarily result in an improved outcome. Studies on these new techniques will hopefully result
in the ultimate goal of reduced morbidity and mortality in the field of fetal tachycardia.  
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